StemCells, Inc. to Present at Cowen & Co. 26th Annual Health Care Conference
PALO ALTO, Calif., (March 6, 2006) – StemCells, Inc. (NASDAQ: STEM) today announced that it will participate in the Cowen & Co. 26 th Annual Health Care Conference scheduled for March 6-9, 2006 at the Boston Marriott Copley Place. Rodney Young, Chief Financial Officer of StemCells, Inc., is scheduled to speak at 10:30 a.m. on Thursday, March 9, 2006. There will be a breakout session following the presentation at which Mr. Young will be available to answer questions about the Company.
A live webcast of the presentation can be accessed via the following link: www.corporate-ir.net/...
#########################
StemCells, Inc. is a development stage biotechnology company focused on the discovery, development and commercialization of stem cell-based therapies to treat diseases of the nervous system, liver and pancreas. The Company’s stem cell programs seek to repair or repopulate neural or other tissue that has been damaged or lost as a result of disease or injury. StemCells is the first company to directly identify and isolate human neural stem cells from normal brain tissue. These stem cells are expandable into cell banks for therapeutic use, which demonstrates the feasibility of using normal, non-genetically modified cells as cell-based therapies. StemCells is a publicly traded company solely focused on stem cell research and development and has approximately 40 U.S. and 100 non-U.S. patents, as well as 100 patent applications pending worldwide. Further information about the Company is available on its web site at: www.stemcellsinc.com.
Apart from statements of historical facts, the text of this press release constitutes forward-looking statements regarding, among other things, the future business operations of StemCells, Inc. (the “Company”). The forward-looking statements speak only as of the date of this news release. StemCells does not undertake to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof. Such statements reflect management’s current views and are based on certain assumptions that may or may not ultimately prove valid.
CONTACT: StemCells, Inc.
Rodney Young
Chief Financial Officer
650-475-3100, Ext. 105
irpr@stemcellsinc.com
or
Schwartz Communications, Inc.
781-684-0770
stemcells@schwartz-pr.com
SOURCE: StemCells, Inc.
|
